Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer

by Michael eKattan
Published 2014-10-01

The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer

by Carvell eNguyen, Brandon eIsariyawongse, Changhong eYu, Michael eKattan
Published 2012-10-01